Abstract
BackgroundTicagrelor, a potent P2Y12 receptor inhibitor, is recommended along with Aspirin as initial therapy for ST Segment Elevation Myocardial Infarction (STEMI).19 Whether Ticagrelor can improve coronary patency before Primary percutaneous...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
